NASDAQ:DOX - Amdocs Stock Price, Price Target & More

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Thursday, May 10th. Stockholders of record on Friday, June 29th will be given a dividend of $0.25 per share on Friday, July 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date of this dividend is Thursday, June 28th. View Amdocs' Dividend History.

Amdocs declared that its board has initiated a share repurchase plan on Thursday, November 9th 2017, which authorizes the company to buyback $800,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its stock is undervalued.

Amdocs Limited (NASDAQ:DOX) posted its earnings results on Thursday, May, 10th. The technology company reported $0.95 EPS for the quarter, hitting analysts' consensus estimates of $0.95. The technology company earned $992.34 million during the quarter, compared to analysts' expectations of $980.59 million. Amdocs had a return on equity of 15.07% and a net margin of 11.36%. The firm's revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the business earned $0.94 earnings per share. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Amdocs.

Amdocs updated its third quarter earnings guidance on Thursday, May, 10th. The company provided EPS guidance of $1.00-1.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.01. The company issued revenue guidance of $990-1030 million, compared to the consensus revenue estimate of $1.00 billion.

6 equities research analysts have issued 1 year price objectives for Amdocs' shares. Their predictions range from $60.20 to $77.00. On average, they anticipate Amdocs' share price to reach $69.24 in the next year. This suggests a possible upside of 0.6% from the stock's current price. View Analyst Ratings for Amdocs.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Amdocs include Wipro (WIT), NTT DATA Corp/ADR (NTDTY), Verisign (VRSN), Obic (OBIIF), EPAM Systems (EPAM), Aspen Technology (AZPN), GEMALTO NV/S (GTOMY), Zscaler (ZS), Sogou (SOGO), Syntel (SYNT), Callidus Software (CALD), Virtusa (VRTU), Luxoft (LXFT), PROS (PRO) and Perficient (PRFT).

News articles about DOX stock have trended positive on Sunday, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Amdocs earned a coverage optimism score of 0.28 on Accern's scale. They also assigned news articles about the technology company an impact score of 45.74 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Amdocs' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Manning & Napier Group LLC (1.33%), Fisher Asset Management LLC (0.14%), State of Alaska Department of Revenue (0.03%), CENTRAL TRUST Co (0.01%) and Atria Investments LLC (0.00%). View Institutional Ownership Trends for Amdocs.

DOX stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Fisher Asset Management LLC and Atria Investments LLC. View Insider Buying and Selling for Amdocs.

DOX stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue and CENTRAL TRUST Co. View Insider Buying and Selling for Amdocs.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $68.81.

Amdocs has a market capitalization of $9.87 billion and generates $3.87 billion in revenue each year. The technology company earns $436.82 million in net income (profit) each year or $3.55 on an earnings per share basis. Amdocs employs 24,670 workers across the globe.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]